@article{3179892,
    title = "IMvigor130: A randomized, phase III study evaluating first-line (1L)
atezolizumab (atezo) as monotherapy and in combination with
platinum-based chemotherapy (chemo) in patients (pts) with locally
advanced or metastatic urothelial carcinoma (mUC).",
    author = "Galsky, Matt D. and Grande, Enrique and Davis, Ian D. and De Santis, and Maria and Arija, Jose Angel Arranz and Kikuchi, Eiji and Mecke, Almut and and Thastrom, Ann Christine and Bamias, Aristotelis",
    journal = "World Journal of Clinical Oncology",
    year = "2018",
    volume = "36",
    number = "15, S",
    publisher = "AMER SOC CLINICAL ONCOLOGY 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA",
    doi = "10.1200/JCO.2018.36.15_suppl.TPS4589"
}